[1]
Kim, M. et al. 2022. ASSOCIATION BETWEEN GLUCOCORTICOID DOSE WITH BMI AND GLUCOCORTICOID-RELATED COMORBIDITIES: DATA FROM TILDACERFONT PHASE 2A TRIALS IN CLASSIC CONGENITAL ADRENAL HYPERPLASIA. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 13. DOI:https://doi.org/10.15605/jafes.037.AFES.13.